66 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
strUKtUr OrGaNIsasI
ORgAnIzATIOnAL STRUCTURE
Direktur Utama
President Director
Arief Budiman
Sekretaris Perusahaan
Corporate Secretary
Yasser Arafat Produksi 1
Production 1
Eni Rohmawati Perencanaan Produksi dan
Pengendalian Persediaan
Production Planning and Inventory Control
Suyatno
Direktur
Director
Muhammad Umar Direktur
Director
Syamsul Hadi
Pengawasan Mutu
Quality Control
Fitrahini Manajemen Rantai Pasokan
Supply Chain Management
Toni Kurniawan Teknologi Informasi
Information Technology
Sofyan Bahri
Teknik dan Pemeliharaan
Engineering and Maintenance
Achmad Yusuf Satuan Pengawasan Intern
Internal Control
Suryadi
Penelitian dan Pengembangan
Research and Development
Sya Indradewi
Pemastian Mutu
Quality Assurance
Eko Dodi Santosa Sumber Daya Manusia dan Umum
Human Resource and General Afairs
Dadang Mulyana
Akuntansi
Accounting
Dewi Fitrianti
Kepatuhan, Kinerja dan Manajeman Risiko
Compliance, Performance, and Risk management
Durokhim Syamsoeri Produksi 2
Production 2
Ichsan Muchtar Djamil Pengadaan
Procurement
Sri Slamet
Irmawati Pemasaran
Marketing
Fudoli Rustam
Perbendaharaan
Treasury
Wardjoko Sumedi
Pengembangan Produk dan Bisnis
Product and Business Development
Pengembangan Produk
Product Development
Lany Marliany Pengembangan Usaha
Business Development
Mario Apriliansyah Pengembangan Jasa Teknik
Indomach
Pharmaceutical Engineering
M. Luthi Ekardi
67 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
PEJaBat EKsEKUtIf
ExECUTIVE OFFICERS
Yasser Arafat Sekretaris Perusahaan
Corporate Secretary Yasser Arafat, SE., 40 tahun, kelahiran Kendal, 11 November 1975,
berdomisili di Bekasi. Memiliki gelar Sarjana bidang Ekonomi Manajemen. Ia telah bekerja di Perseroan selama hampir 16 tahun dan
menekuni bidang database dan teknologi informasi Perseroan sejak awal karirnya sebagai Asisten Manajer Database 2002. Ia dipercaya
untuk menjabat Manajer Teknologi Informasi 2005, kemudian sebagai Manajer Corporate Performance Management 2011. Yasser diangkat
menjadi Sekretaris Perusahaan sejak Juli 2014.
Yasser Arafat, SE, aged 40, born in Kendal, 11 November 1975, domiciled in Bekasi. He holds a Bachelors degree in Economics Management. He
has been working in the Company for nearly 16 years and pursuing his career in database and information technology since irst joint as
Assistant Manager of Database 2002. He was appointed as Information Technology Manager in 2005, Corporate Performance Management
Manager in 2011. Yasser as been serving as Corporate Secretary of the Company since July 2014.
Durokhim Syamsoeri Manajer Kepatuhan, Kinerja Manajemen Risiko
Compliance, Performance Risk Management Manager Durokhim Syamsoeri, SE., 51 tahun, kelahiran Tegal, 23 Juni 1964,
berdomisili di Bekasi. Bergelar Sarjana bidang Ekonomi Akuntansi. Ia telah bekerja di Perseroan selama hampir 12 tahun. Di awal karirnya, ia
telah dipercaya menjadi Manajer Keuangan 2004 kemudian menjabat Manajer Koperasi 2005. Diangkat sebagai Manajer Kepatuhan, Kinerja
Manajemen Risiko sejak Juli 2009.
Durokhim Syamsoeri, SE., aged 51, born in Tegal, 23 June 1964, domiciled in Cibitung. He holds Bachelor of Economics
majoring in Accounting. He has been working in the Company for nearly 12 years. Earlier in his career, he served as Finance
Manager 2004 and then as Cooperatives Manager 2005. He has been serving as Compliance, Performance Risk Management
Manager since July 2009.
68 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
Suryadi Plt. Manajer Satuan Pengawasan Intern
Acting Internal Control Manager Suryadi, SE.,MM.,QIA., 55 tahun, kelahiran Jakarta, 14 Februari 1961,
berdomisili di Bekasi. Memiliki gelar Sarjana Ekonomi dan Magister bidang Manajemen Keuangan. Ia telah bekerja di Perseroan selama
lebih dari 36 tahun dan menekuni bidang treasury dan audit internal Perseroan. Ia dipercaya untuk menjabat Koordinator Seksi Penagihan
dan Penerimaan 1996, Pj. Asisten Manajer Treasury 1999, Asisten Manajer Satuan Pengawasan Intern 2005, dan Asisten Manajer Audit
Operasional dan Kepatuhan 2009. Suryadi diangkat menjadi Plt Manajer Satuan Pengawasan Intern sejak Juni 2014.
Suryadi, SE., MM., QIA., aged 55, born in Jakarta, 14 February 1961, domiciled in Bekasi. He holds Bachelor’s degree in Economics and
Master’s degree in Financial Management. He has been working in the Company for over 36 years and pursuing his career in treasury and
internal audit. He was entrusted to serve as Collection and Revenue Section Coordinator 1996, Acting Assistant Treasury Manager 1999,
Assistant Manager of Internal Audit 2005, and Assistant Manager of Operational and Compliance Audit 2009. Suryadi has been serving as
Acting Internal Audit Unit Manager since June 2014.
Sofyan Bahri Manajer Teknologi Informasi
Information Technology Manager Sofyan Bahri, ST., 43 tahun, kelahiran Jakarta, 18 Februari 1973, berdomisili
di Depok. Bergelar Sarjana bidang Manajemen Informatika. Ia telah bekerja di Perseroan selama lebih dari 12 tahun dan berpengalaman
sebagai Manajer Teknologi Informasi Entitas Anak, PT Indofarma Global Medika. Sofyan diangkat sebagai Manajer Teknologi Informasi sejak
Agustus 2014.
Sofyan Bahri, ST., aged 43, born in Jakarta, 18 February 1973, domiciled in Depok. He holds a Bachelor’s degree in Information Management. He
has been working at the Company for over 12 years with experience as Information Technology Manager of the Company’s Subsidiary,
PT Indofarma Global Medika. Sofyan has been serving as the Company’s Information Technology Manager since August 2014.
PEJABAT EKSEKUTIF
ExECUTIVE OFFICERS
69 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Lany Marliany Manajer Pengembangan Produk
Product Development Manager Lany Marliany, S.Si.,Apt., 39 tahun, kelahiran Bandung, 27 Mei 1976,
berdomisili di Bekasi. Memiliki latar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan selama lebih dari 11 tahun dan telah menekuni
bidang pengembangan produk dan merk produk Perseroan sejak tahun 2004. Memulai karirnya sebagai Asisten Manajer Produk I Branded,
Lany kemudian dipercaya untuk menjadi Manajer Strategic Business Development 2011 dan Manajer Strategi Pengembangan Produk
Kesehatan 2012. Menjabat sebagai Manajer Pengembangan Produk sejak Maret 2015.
Lany Marliany, S.Si., Apt., aged 39, born in Bandung on 27 May 1976, domiciled in Bekasi. She has Pharmacist education. She has been working
in the Company for over 11 years and pursuing her career in product development and product brands since 2004. Starting her career as
an Assistant Product Manager I Branded, Lany was then appointed as Strategic Business Development Manager 2011 and Health Product
Development Strategy Manager 2012 . She has been serving as Product Development Manager since March 2015.
Mario Apriliansyah Manajer Pengembangan Usaha
Business Development Manager Mario Apriliansyah, ST., MT., 41 tahun, kelahiran Jakarta, 12 April 1975,
berdomisili di Jakarta. Bergelar Sarjana Teknik Mesin dan Magister Teknik Industri. Ia telah bekerja di Perseroan selama empat tahun dan menjabat
Manajer Pengembangan Usaha sejak Maret 2012.
Mario Apriliansyah, ST., MT., aged 41, born in Jakarta, 12 April 1975, domiciled in jakarta. He holds Bachelor of Mechanical Engineering and
Master’s degree in Industrial Engineering. He has been working in the Company for four years and serving as Business Development Manager
since March 2012.
70 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
M. Luthi Ekardi Manajer Pengembangan Jasa Teknik Indomach
Engineering Service Development Manager Indomach Ir. M. Luthi Ekardi MBA., M.Eng., 43 tahun, kelahiran Jakarta, 27 Juli 1972,
berdomisili di Jakarta. Memiliki gelar Sarjana bidang Teknik Mesin dan Magister bidang Administrasi Bisnis dan Teknik Mesin. Ia telah bekerja
di Perseroan selama hampir 16 tahun dan telah menekuni unit usaha Indomach sejak tahun 2001. Luthi menjabat sebagai Manajer Indomach
sejak Juli 2013.
Ir. M. Luthi Ekardi MBA., M.Eng., aged 43, born in Jakarta, 27 July 1972, domiciled in Jakarta. He hold a Bachelors degree in Bussiness
Administration and Master’s degree in Industrial Management and Mechanical Engineering. He has been working in the company for nearly
16 years and pursuing his career in Indomach business unit since 2001. Luti has been serving as Indomach Manager since July 2013.
Eni Rohmawati Manajer Produksi 1
Production 1 Manager Eni Rohmawati, S.Si., Apt., M.S.M, 43 tahun, kelahiran Wonogiri, 24 April
1972, berdomisili di Bekasi. Berlatar belakang pendidikan Apoteker dan Magister Sains Manajemen. Ia telah bekerja di Perseroan selama
17 tahun dan telah menekuni bidang produksi Perseroan sejak tahun 1999. Di tahun 2001, ia dipercaya menjadi Asisten Manajer Pengujian
Mikrobiologi, kemudian dipercaya menjadi Manajer Produksi 1 2011 dan Manajer Penelitian dan Pengembangan 2013. Eni kembali diangkat
sebagai Manajer Produksi 1 sejak Juli 2014.
Eni Rohmawati, S.Si., Apt., M.S.M, aged 43, born in Wonogiri, 24 April 1972, domiciled in Bekasi. She has Pharmacist education and Master’s degree
in Management of Sains. She has been working in the Company for 17 years and pursuing her career in production since 1999. In 2001, she
was appointed as Microbiology Testing Assistant Manager, Production 1 Manager in 2011 and Research and Development Manager in 2013.
She was re-appointed as Production 1 Manager in 1 July 2014 to serve up to date.
PEJABAT EKSEKUTIF
ExECUTIVE OFFICERS
71 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Ichsan Muchtar Djamil Manajer Produksi 2
Production 2 Manager Drs. Ichsan Muchtar Djamil, Apt., 48 tahun, kelahiran Padang Pariaman,
27 September 1967, berdomisili di Bekasi. Memiliki latar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan selama lebih dari 22
tahun dan telah menekuni bidang pemasaran dan produksi Perseroan. Di tahun 2001, ia telah dipercaya untuk menjadi Asisten Manajer Grup
Produk Etikal, kemudian dipercaya menjadi Manajer Reguler II 2007 dan Manajer Produksi Farma 2013. Ichsan diangkat sebagai Manajer
Produksi 2 sejak Juli 2014.
Drs. Muchtar Ichsan Djamil, Apt., aged 48, born in Padang Pariaman, 27 September 1967, domiciled in Bekasi. He has Pharmacist education.
He has been working in the Company for over 22 years and involved in marketing and production of the Company. In 2001, he was appointed
as Assistant Manager of Ethical Product Group, Regular Manager II 2007 and Pharmacy Production Manager 2013. Ichsan was appointed as
Production 2 Manager in July 2014 to serve up to date.
Sya Indradewi Manajer Penelitian dan Pengembangan
Research and Development Manager Dra. Sya Indradewi, 55 tahun, kelahiran Solo, 16 April 1960, berdomisili
di Bekasi. Berlatar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan selama 30 tahun. Di tahun 2002 dipercaya menjabat Manajer
Penelitian dan Pengembangan, kemudian berkesempatan untuk memegang beberapa posisi manajerial seperti Manajer Produksi 2 2005,
Manajer QAQC 2010 dan Manajer Mutu dan Pengembangan 2013. Sya kembali diangkat sebagai Manajer Penelitian dan Pengembangan
pada Mei 2015.
Dra. Sya Indradewi, aged 55, born in Solo, 16 April 1960, domiciled in Bekasi. She has Pharmacist education. She has been working in the
Company for 30 years. She was entrusted as Research and Development Manager in 2002 and subsequently held several managerial positions
such as Production 2 Manger 2005, QA QC Manager 2010 and Quality and Development Manager 2013. Sya was re-appointed as Research
and Development Manager in May 2015 to serve up to date.
72 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
Fitrahini Plt. Manajer Pengawasan Mutu
Acting Quality Control Manager Fitrahini, S.Si. Apt., 41 tahun, kelahiran Jakarta, 12 Juli 1974, berdomisili
di Bekasi. Memiliki latar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan lebih dari 13 tahun dan telah menekuni bidang produksi
Perseroan sejak karir awalnya. Di tahun 2007, ia diangkat sebagai Asisten Manajer Pengadaan Bahan, Asisten Manajer Pengujian Bahan
Awal dan Bahan Pengemas 2011, kemudian Asisten Manajer IPC dan Pengujian Produk 2013. Fitrahini diangkat menjadi Plt. Manajer
Pengawasan Mutu sejak Juni 2014.
Fitrahini, S.Si.Apt., aged 41, born in Jakarta, 12 July 1974, domiciled in Bekasi. She has Pharmacist education. She has been working in
the Company for more than 13 years and involving in the Company’s production since the beginning of career. In 2007, she was appointed
as Materials Procurement Assistant Manager, Starting Material and Packaging Materials Testing Assistant Manager 2011, IPC and Product
Testing Assistant Manager 2013. Fitrahini was appointed as Acting Quality Control Manager in June 2014 to serve up to date.
Suyatno Manajer Perencanaan Produksi dan Pengendalian Persediaan PPPP
Production Planning and Inventory Control Manager Suyatno, S.Si. Apt., 41 tahun, kelahiran Wonogiri, 25 April 1974,
berdomisili di Bekasi. Berlatar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan selama lebih dari 16 tahun dan telah menekuni
bidang produksi Perseroan sejak tahun 2000. Di tahun 2003, ia telah dipercaya menjabat Asisten Manajer Pengemasan, kemudian dipercaya
menjadi Manajer SCM 2010. Suyatno diangkat sebagai Manajer PPPP sejak Agustus 2014.
Suyatno, S.Si. Apt., aged 41, born in Wonogiri, 25 April 1974, domiciled in Bekasi. He has pharmacist education. He has been working in the
Company for more than 16 years and pursuing her career in production since 2000. He was entrusted to serve as Packaging Assistant Manager
in 2003 and SCM Manager in 2010. Suyatno was appointed as Production Planning and Inventory Control Manager on August 2014
to serve up to date.
PEJABAT EKSEKUTIF
ExECUTIVE OFFICERS
73 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Sri Slamet Irmawati Manajer Pengadaan
Procurement Manager Dra. Sri Slamet Irmawati, 56 tahun, kelahiran Cimahi, 11 Januari 1960,
berdomisili di Bandung. Memiliki latar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan selama 12 tahun dan memulai karirnya
sebagai Asisten Manajer Metode Analisa dan Stabilitas 2004. Sri kemudian dipercaya untuk menjabat Asisten Manajer Pengadaan Bahan
2009, kemudian menjadi Manajer Pengadaan sejak November 2011.
Dra. Sri Slamet Irmawati, aged 56, born in Cimahi, 11 January 1960, domiciled in Bandung. She has Pharmacist education. She has been
working in the Company for 12 years starting her career as Analysis and Stability Methods Assistant Manager in 2004. Sri was then entrusted
as Material Procurement Assistant Manager in 2009 and Procurement Manager in November 2011 to serve up to date.
Eko Dodi Santosa Manajer Pemastian Mutu
Quality Assurance Manager Eko Dodi Santosa, S.Si., Apt., 47 tahun, kelahiran Sleman, 5 Maret
1969, berdomisili di Bekasi. Berlatar belakang pendidikan Apoteker. Ia telah bekerja di Perseroan selama 21 tahun dan mengawali karirnya
di Perseroan sebagai Apoteker. di Litbang. Pernah menjabat sebagai Manajer QAQC 2008, diangkat menjadi Manajer Pemastian Mutu
2012, kemudian dipercaya menjabat Manajer Corporate Performance 2013. Dodi kembali diangkat sebagai Manajer Pemastian Mutu pada
Maret 2014.
Eko Dodi Santosa, S.Si., Apt., aged 47, born in Sleman, 5 March 1969, domiciled in Bekasi. He has Pharmacist education. He holds Pharmacist
education. He has been working in the Company for 21 years starting his career as Pharmacist in RD. He was QAQC Manager in 2008, Quality
Assurance Manager in 2012 and Corporate Performance Manager in 2013. Dodi was reappointed as Quality Assurance Manager in March
2014 to serve up to date.
74 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
Toni Kurniawan Manajer Manajemen Rantai Pasokan
Supply Chain Management Manager Toni Kurniawan, S.Si., Apt., MM., 47 tahun, kelahiran Jakarta, 28
September 1968, berdomisili di Depok. Memiliki gelar Apoteker dan Magister bidang Manajemen. Ia telah bekerja di Perseroan selama lebih
dari 13 tahun dan berpengalaman dalam manajerial Entitas Anak, PT Indofarma Global Medika. Toni diangkat sebagai Manajer SCM sejak
Agustus 2014.
Toni Kurniawan, S.Si., Apt., MM., aged 47, was born in Jakarta, 28 September 1968, domiciled in Depok. He holds Bachelor’s degree in
Pharmachist and Master’s degree in Management. He has been working in the Company for more than 13 years with managerial experience
in the Company’s subsidiary, PT Indofarma Global Medika. Toni was appointed as SCM Manager in August 2014 to serve up to date.
Achmad Yusuf Manajer Teknik dan Pemeliharaan
Engineering and Maintenance Manager Ir. Achmad Yusuf, 47 tahun, kelahiran Padang, 22 Maret 1969, berdomisili
di Jakarta. Bergelar Sarjana bidang Teknik Elektronika. Ia telah bekerja di Perseroan selama lebih dari 19 tahun dan telah menekuni bidang
teknik Perseroan sejak awal bergabung di tahun 1996. Di tahun 1999, ia telah dipercaya menjabat Asisten Manajer Pemeliharaan, kemudian
Manajer Teknik dan Pemeliharaan 2002 dan Manajer Umum 2006. Yusuf diangkat kembali sebagai Manajer Teknik dan Pemeliharaan
sejak Maret 2012.
Ir. Achmad Yusuf, aged 47, born in Padang, 22 March 1969, domiciled in Jakarta. He holds a Bachelor’s degree in Electrical Engineering. He
has been working in the Company for more than 19 years pursuing his career in engineering since irst joining in 1996. He was appointed as
Maintenance Assistant Manager in 1999, Maintenance and Engineering Manager in 2002 and General Afairs Maager in 2006. Yusuf was
reappointed as Engineering and Maintenance Manager in March 2012 to serve up to date.
PEJABAT EKSEKUTIF
ExECUTIVE OFFICERS
75 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Fudoli Rustam Manajer Pemasaran
Marketing Manager Fudoli Rustam, SE., MM., 45 tahun, kelahiran Brebes, 14 Agustus 1970,
berdomisili di Bekasi. Memiliki gelar Sarjana Ekonomi dan Magister bidang Manajemen. Ia telah bekerja di Perseroan selama lebih dari 12 tahun dan
telah menekuni bidang pemasaran Perseroan sejak tahun 2003. Mengawali karirnya sebagai Asisten Manajer Penjualan wilayah Tengah, kemudian
dipercaya untuk menjabat Manajer OTC 2007, Manajer Riset Pasar 2012 dan Manajer Herbal 2013. Fudoli diangkat sebagai Manajer Marketing
sejak September 2013.
Fudoli Rustam, SE., MM., aged 45, born in Brebes, 14 August 1970, domiciled in Bekasi. He holds Bachelor’s degree in Economy and Master’s degrees
in Management. He has been working in the Company for 12 years and involving in Marketing since 2003. He started his career as Central Regional
Manager Assistant Manager and then was appointed as OTC Manager in 2007, Market Research Manager in 2012 and Herbal Manager in 2013.
Fudoli was appointed as Marketing Manager in September 2013 to serve up to date.
Dadang Mulyana Manajer Sumber Daya Manusia dan Umum
Human Resources and General Afairs Manager Dadang Mulyana, Ak., M.Si., 50 tahun, kelahiran Cirebon, 11 Juli 1965,
berdomisili di Bekasi. Bergelar Sarjana Akuntansi dan Magister bidang Sosial Politik. Ia telah bekerja di Perseroan selama lebih dari 11 tahun
dan berpengalaman sebagai Manajer Satuan Pengawasan Intern di awal karirnya 2004. Ia juga dipercaya untuk menjabat Manajer
Perencanaan dan Pengendalian Keuangan 2006 dan Manajer Operasional dan Pengembangan Anak Perusahaan dan Mitra 2013. Dadang diangkat
sebagai Manajer SDM dan Umum sejak Juni 2014.
Dadang Mulyana, Ak., M.Si., aged 50, born in Cirebon, 11 July 1965, domiciled in Bekasi. He holds a Bachelor’s degree in Accounting and
Master’s degree in Social Politics. He has been working for more than 11 years and started his career in 2004 as Internal Control Unit Manager. He
was appointed as Financial Planning and Control Manager in 2006 and Operations and Partner and Subsidiary Development Manager in 2013.
Dadang has been serving as HR and General Afairs since 2014.
76 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
Warjoko Sumedi Plt. Manajer Perbendaharaan
Acting Treasury Manager Warjoko Sumedi, SE., 44 tahun, kelahiran Boyolali, 30 Mei 1971, berdomisili
di Bekasi. Memiliki gelar Sarjana bidang Ekonomi Manajemen. Ia telah bekerja di Perseroan selama hampir 21 tahun dan menekuni bidang aset
dan perbendaharaan Perseroan sejak karir awalnya. Ia diangkat menjadi Asisten Manajer Keuangan sejak Oktober 2008 dan kemudian dipercaya
menjadi Plt. Manajer Perbendaharaan pada Maret 2013.
Warjoko Sumedi, SE., aged 44, born in Boyolali, 30 May 1971, domiciled in Bekasi. He holds a Bachelor’s degree in Economics Management. He
has been working in the Company for nearly 21 years pursuing his career in assets and treasury since irst joining. He was appointed as Finance
Assistant Manager on October 2008 and then as Acting Treasury Manager in 2013 to serve up to date.
Dewi Fitrianti Manajer Akuntansi
Accounting Manager Dewi Fitrianti, SE., Ak., CPA., 37 tahun, kelahiran Jakarta, 1 Februari 1979,
berdomisili di Bogor. Bergelar Sarjana Ekonomi Akuntansi dan telah bekerja di Perseroan selama lebih dari tiga tahun. Ia menjabat Manajer
Akuntansi sejak Oktober 2012.
Dewi Fitrianti, SE., Ak., CPA, aged 37, born in Jakarta, 1 February 1979, domiciled in Bogor. She hold a Bachelor’s degree in Economics majoring
in Accounting and has been working in the Company for more than 3 years. She was appointed as Accounting Manager in October 2012 to
serve up to date.
PEJABAT EKSEKUTIF
ExECUTIVE OFFICERS
77 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
PEMEGaNG saHaM UtaMa, strUKtUr GrUP DaN ENtItas aNaK
MAJOR SHAREHOLDERS, gROUP STRUCTURE AnD SUBSIDIARIES
Pemerintah Republik Indonesia
80,66
Indonesian Government
PT Indofarma Persero Tbk
PT Indofarma Global Medika
PT Farmalab Indoutama
Publik
19,34
99,999
99
Public
78 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
Entitas anak
Subsidiary
PT Indofarma Global Medika IGM
Jenis Usaha Type of Business
:
Distribusi serta perdagangan obat dan alat kesehatan Engaged in wholesale distribution and trade of drugs and medical equipment
Tanggal Penyertaan Date of Investment
:
4 Januari 2000 January 4, 2000
Status Operasi Operational Status
Beroperasi In Operation
Kepemilikan oleh Perseroan Ownership by the Company
: ®
PT Indofarma Persero Tbk. 99,999 ®
Koperasi Pegawai Indofarma 0,001
Modal Dasar Authorized Capital
:
Rp200.000.000.000 dua ratus miliar rupiah Rp200,000,000,000 two hundred billion rupiah
Modal Ditempatkan dan Disetor Penuh Issued and Paid Up Capital
:
Rp120.000.000.000 seratus dua puluh miliar rupiah Rp120,000,000,000 one hundred and twenty billion rupiah
Alamat Kantor Oice Address
:
Kantor Pusat Head Oice
Komplek Ininia Park, Jl. Dr. Sahardjo No. 45, Blok B-86 Jakarta 12850, Indonesia Tel: +62 21 8378 8166, Fax: +62 21 8378 5432
Email: infoigm.co.id, Web: www.igm.co.id Jumlah Kantor Cabang
Number of Branches
:
34 kantor, yang tersebar diseluruh Indonesia 34 branches across Indonesia
Aset Assets
:
31 Desember 2014 31December 2014
: Rp643.101.346.540 31 Desember 2015
31 December 2015 : Rp919.612.605.570
79 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Entitas anak Kepemilikan tidak Langsung
Indirect Ownership Subsidiary
PT Farmalab Indoutama
Jenis Usaha Type of Business
:
Laboratorium Bioavailabilitas dan Bioekivalensi Bioavailability and Bioequivalence Laboratory
Tanggal Penyertaan Date of Investment
: 17 Desember 2013
December 17, 2013 Status Operasi
Operational Status
Beroperasi
In Operation Kepemilikan
Ownership
: ®
PT Indofarma Global Medika 99 ®
Koperasi Pegawai Indofarma 1
Modal Dasar Authorized Capital
: Rp20.000.000.000 dua puluh miliar rupiah
Rp20,000,000,000 twenty billion rupiah Modal Ditempatkan dan Disetor Penuh
Issued and Paid Up Capital
: Rp5.500.000.000 lima miliar lima ratus juta rupiah
Rp5,500,000,000 ive billion and ive hundred milion rupiah
Alamat Kantor Oice Address
: Kantor Pusat
Head Oice
Jl. Delima II no. 4 Malakasari, Duren Sawit, Jakarta Timur Tel: +62 21 8661 7112
Email: infofarmalab-iu.com Web: www.farmalab-iu.com
Aset
:
31 Desember 2014 31December 2014
: Rp6.671.363.710 31 Desember 2015
31 December 2015 : Rp5.369.326.429
80 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
WILayaH OPErasIONaL
OPERATIOnAL AREAS
region Branch Name
- IGM Pusat
1 Banda Aceh
1 Bandung
1 Batam
1 Jakarta II
1 Medan
1 Padang
1 Pekan Baru
region Branch Name
2 Banjarmasin
2 Cirebon
2 Jakarta I
2 Jambi
2 Lampung
2 Palembang
2 Pontianak
2 Samarinda
region Branch Name
3 Bogor
3 Denpasar
3 Kupang
3 Mataram
3 Purwokerto
3 Semarang
3 Serang
3 Solo
3 Tangerang
3 Yogyakarta
region Branch Name
4 Bekasi
4 Jember
4 Makasar
4 Malang
4 Manado
4 Papua
4 Surabaya
81 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
82 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
INfOrMasI saHaM DaN EfEK LaINNya
SHARES AnD OTHER SECURITIES
per 31 Desember 2015 as per December 31, 2015
Pemegang saham shareholder
total saham lembar total shares in shares
Persentase Kepemilikan of Ownership
• Saham Seri A Dwiwarna
Series A-Dwiwarna share »
Pemerintah RI »
Government of the Republic of Indonesia •
Saham Seri B Series B share
» Pemerintah RI
» Government of the Republic of Indonesia
» Publik kepemilikan kurang dari 5
» Public below 5 ownership
1
2.499.999.999 599.267.500
0,00
80,66 19,34
Total 3.099.267.500
100,00
Komposisi Pemegang saham
Company’s Shareholder Composition
80.66 Pemerintah Republik Indonesia The Government of the Republic of Indonesia
19.34 Publik Public
Komposisi Kepemilikan saham selama 5 tahun terakhir per 31 Desember di setiap tahunnya
Composition of Shareholders ownership Last 5 year as per 31 December each year
Selama 5 lima tahun terakhir, tidak ada perubahan dalam jumlah lembar saham dan persentase kepemilikan Pemerintah
RI dan publik dengan kepemilikan masing-masing di bawah 5. Aksi korporasi Perseroan terakhir berupa Konversi Saham
dilakukan pada tahun 2002, seperti yang dijelaskan di bagian Kronologi Kepemilikan Saham.
During 5 ive years, there was no change in the total and percentage of shares owned by the Government of Indonesia
and public with below 5 share ownership. The Company’s Corporate action which was share convertion was last
conducted in 2002, as described in the of Share Ownership Chronology Section.
80,66 80,66
80,66 80,66
100 80
60 40
20
2011 2012
2013 2014
2015
80,66
14,58 13,66
14,41 11,82
15,60 4,44
4,24 6,66
2,93 0,11
0,08 0,07
0,07 1,13
0,61 0,78
0,74 3,81 0,12
0,83
Pemerintah RI Ritel Domestik
Institusi Domestik Ritel Asing
Institusi Asing
83 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
per 31 Desember 2015 as per December, 31 2015
status Pemegang saham
Shareholder Status
Jumlah Pemilik
Total Shareholders
total saham lembar
Total Shares in shares
Persentase Kepemilikan
of Ownership
Pemodal Domestik
| Domestic Investors Ritel Domestik
| Domestic Retail •
Perorangan | indvidual
• Karyawan Perseroan
| The Company’s employees
3.145 453
446.633.032 5.187.500
14,41 0,17
Institusi Domestik | Domestic
• Dana Pensiun
| Pension Fund •
Asuransi | Insurance
• Perseroan Terbatas
| LLC •
Reksa Dana | Mutual Funds
6 1
20 8
4.502.100 6.906.000
55.851.326 50.725.842
0,15 0,22
1,80 1,64
Jumlah Pemodal Domestik Total Domestic Investors
3.633 569.805.800
18,39 Pemodal Asing
| Foreign Investors Ritel Asing
| Foreign Retail 23
3.595.300 0,12
Institusi Asing | Foreign Institutions
8 25.866.400
0,83
Jumlah Pemodal Asing Total Foreign Investors
31 29.461.700
0,95 Jumlah
| Total
3.664 599.267.500
19,34
Kelompok Pemegang saham Masing-masing Kurang dari 5
Shareholders Categorized below 5Each
Jumlah Pemegang saham Masing-masing Kurang dari 5 sepanjang tahun 2015
Total Shareholders Below 5 Each in 2015
3.900 3.800
3.700 3.600
3.500 3.400
3.300 3.200
3.100 3.000
3.374 3.749
3.556 3.470
3.495 3.823
3.284 3.641
3.515 3.433
3.711 3.664
Jan 2015 Feb 2015
Mar 2015 Apr 2015
May 2015 Jun 2015
Jul 2015 Aug 2015
Sep 2015 Oct 2015
Nov 2015 Dec 2015
84 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
INfOrMasI BaGI INvEstOr
InFORMATIOn FOR InVESTORS
KRONOLOGI PENCATATAN SAHAM DAN PERATURAN KEPEMILIKAN SAHAM
Perseroan dibentuk dari sejarah panjang nasionalisasi aset Pemerintah Kolonial Belanda yang kemudian diubah menjadi
Pusat Produksi Farmasi Departemen Kesehatan Republik Indonesia. Di tahun 1981, pemerintah memutuskan untuk
mentransformasikan Pusat Produksi Farmasi Departemen Kesehatan Republik Indonesia menjadi Perusahaan Umum
Indonesia Farma, atau Perum Indofarma, cikal bakal Perseroan hingga hari ini. Bercermin pada sejarah ini, negara—
dalam hal ini pemerintah—memiliki kuasa penuh atas keberadaan Perseroan.
Initial Public Ofering IPO, atau Penawaran Saham Umum Perdana Perseroan di tahun 2001 memberikan dampak yang
besar terhadap aspek kepemilikan Perseroan. Sebanyak 596.875.000 lembar saham berkode INAF dilepas kepada
publik—saham Seri B—di Bursa Efek Jakarta dan Bursa Efek Surabaya dengan harga penawaran perdana sebesar Rp250
per lembar saham; melengkapi saham Pemerintah RI sebanyak CHRONOLOGY OF SHARES LISTING
AND SHARES OWNERSHIP RULES The Company was formed from a long history of nationalization
of the Dutch colonial government’s assets converted into a Pharmacy Production Center of Department of Health of the
Republic of Indonesia. In 1981, the government decided to transform the Pharmacy Production Center of Department
of Health of the Republic of Indonesia to Perusahaan Umum Indonesia Farma, or Perum Indofarma, the Company’s
beginning. Based on the history, the state -in this case government- has a full authority over the Company’s existence.
The Company’s Initial Public Ofering IPO in 2001 greatly impacted the Company’s ownership aspect. A total of
596,875,000 shares under share code INAF issued to the public – series B common shares - in the Jakarta Stock Exchange and
Surabaya Stock Exchange with the initial offering price of Rp250 per share; to complete the Government of Indonesia’s
2.5 billion shares consisting of 1 preferred Series A Dwiwarna
85 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Share and 2,499,999,999 Series B common shares. A year later, the Company decided to exercise Shares Conversion Corporate
Action, making the Company’s total shares amounting to 3,099,267,499 Series B common shares and 1 shares of Series
A Dwiwarna Share.
Chronology of Shares Listing
The policy to exercise IPO was undertaken to strengthen the Companys capital. Approximately 53 of the IPO
proceeds were realized for facilities and production capacity development, while the other 47 was realized for additional
working capital.
The Government as the ultimate shareholder decided to issue Series A Dwiwarna Shares - or better known as Preferred
Shares - as a strategy to encourage the Government’s role in promoting State Owned Enterprises SOEs to be the national
economy organizer for the community welfare. The 2003 Law No. 19 on State Owned Enterprises SOEs clearly states that
SOEs are established for the purpose of becoming one of the pillars of Indonesian economic democracy.
However, the Company’s legal standing status as a public company requires respect for the rights of all shareholders
without exception, including minority shareholders. The rights of shareholders are as described in the 2003 Law No. 19 and the
2007 Law No. 40 regarding Limited Liability Company detailing the shareholders’ rights and participation. The Company also
amended its Articles of Association in 2015 to mention the rights and role of shareholders, in particular in the General
Meeting of Shareholders GMS. 2,5 miliar lembar yang terdiri dari 1 lembar saham preferen Seri
A Dwiwarna dan 2.499.999.999 lembar saham Seri B. Setahun kemudian, Perseroan mengambil kebijakan aksi korporasi
untuk melakukan Konversi Saham. Sehingga di akhir tahun 2002, Perseroan memiliki 3.099.267.499 lembar saham Seri B
dan 1 lembar saham Seri A Dwiwarna.
Kronologi Pencatatan saham aksi Korporasi
Corporate Action
tanggal Pencatatan
Date of Share Listing
Penambahan saham
Share Addition
akumulasi saham
Share Accummulation
lembar shares
lembar shares
Pra Penawaran Umum Perdana Pre-Initial Public Ofering
17 April 2001 -
2.500.000.000 Penawaran Umum Perdana
Initial Public Ofering 17 April 2001
596.875.000 3.096.875.000
Konversi Saham Share Conversion
26 August 2002 2.392.500
3.099.267.500
Kebijakan IPO ditempuh untuk memperkuat permodalan Perseroan. Lebih kurang 53 dari dana hasil IPO direalisasikan
untuk pengembangan sarana dan kapasitas produksi. Sementara 47 sisanya direalisasikan untuk penggunaan tambahan
modal kerja.
Pemerintah selaku pemilik modal utama mengambil kebijakan saham Seri A Dwiwarna—atau yang lebih dikenal sebagai
saham preferen atau saham istimewa—sebagai langkah strategi terkait entitas Badan Usaha Milik Negara BUMN dari Perseroan
yang mempersyaratkan peran pemerintah untuk mendorong BUMN menjadi penyelenggara perekonomian nasional guna
kesejahteraan masyarakat. Undang-undang No. 19 Tahun 2003 tentang BUMN tegas menyebutkan tujuan pembentukan
BUMN untuk memberikan sumbangan bagi perkembangan perekonomian nasional pada umumnya, dan penerimaan negara
pada khususnya.
Namun demikian, status legal standing Perseroan sebagai perusahaan publik mempersyaratkan penghormatan kepada
hak seluruh pemegang saham tanpa terkecuali, termasuk pemegang saham minoritas. Hak-hak pemegang saham, seperti
yang telah diuraikan dalam Undang-undang No. 19 Tahun 2003 dan Undang-Undang No. 40 Tahun 2007 tentang Perseroan
Terbatas menjabarkan hak dan kewenangan pemegang saham. Perseroan pun memiliki Anggaran Dasar yang baru mengalami
perubahan di tahun 2015 yang juga mencantumkan hak dan wewenang pemegang saham, khususnya dalam Rapat Umum
Pemegang Saham RUPS.
86 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
Agar setiap pemegang saham memahami peraturan kepemilikan dan hak dari jenis saham Seri A Dwiwarna dan Seri B yang dimiliki
Perseroan, di bawah ini disajikan tabel terkait hal-hal tersebut.
Jenis saham, Peraturan Kepemilikan dan Hak Pemegang saham Jenis saham
Type Shares
Peraturan Kepemilikan
Ownership Rules
Hak
Rights
Saham Seri A Dwiwarna
Series A Dwiwarna Shares
Pasal 52 Ayat 1 UU Perseroan Terbatas Article 52 Paragraph 1, Limited Liability
Company Law Menghadiri dan mengeluarkan suara dalam RUPS, menerima pembayaran Dividen
dan sisa kekayaan hasil likuidasi, menjalankan hak lainnya berdasarkan UU Perseroan Terbatas dan Anggaran Dasar Perseroan.
Attend and vote in the GMS, receiving dividends payment and the remainder of the proceeds of the liquidation, obtain other rights based Limited Liability Company Law
and the Company’sArticles of Association.
Saham Seri B Series B Shares
Pasal 17 Ayat 7 dan 8 Anggaran Dasar Perseroan
Article 17 Paragraphs 7 and 8 of the Articles of Association
Mengusulkan calon anggota Direksi kepada RUPS. Propose candidates for the Board of Directors to the GMS.
Pasal 20 Ayat 12 Anggaran Dasar Perseroan Article 20 Paragraph 12 Articles of Association
Mengusulkan calon anggota Dewan Komisaris kepada RUPS. Propose candidates for the Board of Commissioners to the GMS.
Pasal 24 Ayat 8 Anggaran Dasar Perseroan Article 24, Paragraph 8 of the Articles of
Association Diperbolehkan untuk tidak mengambil bagian Dividen dalam waktu 5 lima tahun
setelah disediakan untuk dibayarkan. Permitted not receive dividends payment within ive 5 years after provided to be paid.
Pasal 52 Ayat 1 UU Perseroan Terbatas Article 52 Paragraph 1, Limited Liability
Company Law Menghadiri dan mengeluarkan suara dalam RUPS, menerima pembayaran Dividen
dan sisa kekayaan hasil likuidasi, menjalankan hak lainnya berdasarkan UU Perseroan Terbatas dan Anggaran Dasar Perseroan
Attend and vote in the GMS, receive dividends payment and the remainder of the proceeds of the liquidation, run the other rights based Limited Liability Company Law
and the Articles of Association of the Company.
Secara umum, saham Seri A Dwiwarna tidak menunjukkan tendensi atas monopoli dalam proses pengambilan keputusan.
Perbedaan utama terletak pada hak yang melekat pada saham tersebut dalam mengusulkan calon anggota Direksi dan
Dewan Komisaris kepada RUPS; serta diperbolehkan tidak mengambil bagian dividen dalam waktu 5 lima tahun setelah
dividen tersedia untuk dibayarkan. Hak mengusulkan Direksi dan Dewan Komisaris merupakan bagian dari aspek strategis
terkait pengelolaan Perseroan yang harus tetap mengacu kepada entitas ke-BUMN-annya. Di luar itu, saham Seri A
Dwiwarna tidak memiliki hak untuk mengambil keputusan secara sepihak. Proses pengambilan keputusan, baik dalam
proses RUPS sendiri maupun proses pengubahan Anggaran Dasar sepenuhnya mengacu UU tentang Perseroan Terbatas,
Anggaran Dasar Perseroan dan peraturan serta perundang- undangan yang berlaku.
InFORMASI BAgI InVESTOR
InFORMATIOn FOR InVESTORS
In order to have all shareholders understand the regulation of ownership and the right of Series A Dwiwarna shares and
Series B shares owned by the Company, the following table is presented:
Type of Shares, Ownership Rules and Rights of Shareholders
In general, Series A Shares does not show a monopoly tendency in the decision making process. The main diference lies on
the inherent right of the shares to propose candidates for the Board of Directors and the Board of Commissioners to the GMS;
and to receive dividends payments within 5 ive years upon availability of dividends for payment. The rights to propose
the Board of Directors and the Board of Commissioners are part of the strategic aspects related to the management of
the Company based on its status as SOE. Other than that, the Series A Shares have no right to take unilteral decisions. As
stated in the Company’s Articles of Association, the decision- making process, both at the GMS and amendment to Articles
of Association shall fully refer to Limited Liability Company Law, Article of Association, other regulation.
87 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
Dividend Policy In accordance to the Articles of Association, dividend policy
is from net proit deducted with reserve for losses. Dividends can only be distributed if the Company has a positive
proit balance. Unless decided otherwise in the GMS, this policy serves as the basis of decision-making related to the
distribution of dividends.
The Company can distribute interim dividends before the the end of its inancial year, as requested by 110 of shareholders
representing the total shares issued by the Company, with due regard to the Company’s inancial and proit projections
and also in accordance with prevailing laws and regulations. Interim dividend distributions are determined based on
the decision of the Board of Directors upon the Board of Commissioners’ approval.
If by the end of inancial year the Company records a loss, shareholders shall return the distributed interim dividend
to the Company. The Board of Directors and Board of Commissioners are jointly accountable for the loss in the
event the Companys shareholders fail to return the interim dividends that are already distributed.
Chronology of Dividend distribution within 5 ive years is as presented in the table below.
Chronology of Dividend Distribution in Last 5 Five years
The years marked with N A in the table above were the years when the Company did not distribute dividends in accordance
with the basic policy related to dividend distribution mentioned above. In 2010, the Company did not distribute
dividends as retained earnings were reserved for losses. In 2011, there was a decision for not distributing dividends due
to insuiciency of the Company’s proit in consideration with the growth acceleration performance, business expansion
and capital expenditure needs. In 2013, the Company did not distribute dividends as it recorded loss. In 2014, the Company
did not distribute proit as a consequence of the need for the 2015 working capital.
Kebijakan Dividen Sesuai Anggaran Dasar Perseroan, kebijakan pembagian
dividen dilakukan dari seluruh laba bersih setelah dikurangi penyisihan untuk cadangan kerugian. Dividen hanya dapat
dibagikan jika Perseroan mempunyai saldo laba positif. Kecuali RUPS memutuskan hal lain, kebijakan ini berlaku sebagai
dasar dari pengambilan keputusan terkait pembagian dividen.
Perseroan dapat membagikan dividen interim sebelum tahun buku Perseroan berakhir apabila diminta oleh pemegang
saham yang mewakili 110 dari bagian saham yang telah dikeluarkan Perseroan, dengan memperhatikan proyeksi
laba dan keuangan serta peraturan perundang-undangan yang berlaku. Pembagian dividen interim ditetapkan
berdasarkan keputusan Direksi setelah mendapat persetujuan Dewan Komisaris.
Jika setelah tahun buku berakhir ternyata Perseroan menderita kerugian, dividen interim yang dibagikan harus dikembalikan
oleh pemegang saham kepada Perseroan. Direksi dan Dewan Komisaris bertanggung jawab secara tanggung
renteng terhadap kerugian Perseroan dalam hal pemegang saham tidak dapat mengembalikan dividen interim yang
telah dibagikan.
Kronologi pembagian dividen selama 5 lima tahun terakhir dapat dilihat pada tabel di bawah ini.
Kronologi Pembagian Dividen selama 5 Lima tahun terakhir
tahun Buku
Financial year
tanggal Pengumuman
Date of Announcement
tanggal Pembayaran
Date of Payment
Dividen Kas yang Dibagikan
Distributed Dividend
Dividen per Lembar saham
Dividend per shares
rasio Pembagian Dividen
Dividend Pay-Out Ratio 2010
NA 2011
NA 2012
15 April 2013 22 Mei 2013
Rp4.238.511.497 Rp1,36
10,11 2013
NA 2014
NA
NA = Not Available
Tahun-tahun dimana penanda NA terlihat pada tabel di atas, Perseroan tidak melakukan pembagian dividen sesuai dengan
kebijakan terkait pembagian dividen seperti yang telah disebutkan di atas. Tahun 2010, Perseroan tidak membagikan
dividen karena laba ditahan untuk cadangan kerugian. Di tahun 2011, kebijakan untuk tidak membagikan dividen
dilakukan dengan pertimbangan akselerasi pertumbuhan kinerja, ekspansi usaha serta kebutuhan capital expenditure.
Tahun 2013 Perseroan tidak membagikan dividen karena terjadi kerugian. Di tahun 2014, Perseroan kembali tidak
membagikan laba sebagai konsekuensi kebutuhan akan modal kerja untuk tahun 2015.
88 Laporan Tahunan 2015 PT Indofarma Persero Tbk
Menjaga Kinerja Berkelanjutan untuk Performa yang Prima
PENGHarGaaN DaN sErtIfIKasI
ACKnOWLEDgEMEnTS AnD CERTIFICATIOnS
Sertiikat dan penghargaan yang diterima oleh Perseroan selama 5 lima tahun terakhir adalah sebagai berikut:
IsO
tanggal
Date
Jenis sertiikat
Certiicates
Dikeluarkan oleh
Certied by
Masa Berlaku hingga
Valid Until 17 March 2012
ISO 9001: 2008 Issue 7 No. ID0300102 Manufacturing and Marketing of Pharmaceutical Products, Herbal medicine, Injection, Drop, Tablet, Capsule, Powder, Ointment, Cream,
Syrup, Dry Syrup, Suspension, Solution, and Sachet SGS
17 March 2015 17 March 2015
ISO 9001: 2008 Issue 8 No. ID0300102 Manufacturing and Marketing of Pharmaceutical Products, Herbal medicine, Injection, Drop, Tablet, Capsule, Powder, Ointment, Cream,
Syrup, Dry Syrup, Suspension, Solution, and Sachet SGS
17 March 2018
CPOB
tanggal
Date
Jenis sertiikat
Certiicates
Dikeluarkan oleh
Certied by
Masa Berlaku hingga
Valid Until 14 December 2012
CPOB No. 3865CPOBAXII12, Bentuk Sediaan Semisolid Nonbetalaktam GMP No. 3865CPOBAXII12, for Nonbetalactam Semisolid
Badan POM 14 December 2017
9 April 2015 CPOB No. 4361CPOBAIV15, Bentuk Sediaan Tablet Biasa dan Tablet Salut Nonbetalaktam
GMP No. 4361CPOBAIV15 , for Nonbetalactam Tablets and Coated Tablets Badan POM
7 April 2020 9 April 2015
CPOB No. 4362CPOBAIV15, Bentuk Sediaan Kapsul Keras Nonbetalaktam GMP No. 4362CPOBAIV15, for Nonbetalactam Hard Capsules
Badan POM 7 April 2020
9 April 2015 CPOB No. 4363CPOBAIV15, Bentuk Sediaan Serbuk Oral Nonbetalaktam
GMP No. 4363CPOBAIV15, for Nonbetalactam Oral Powder Badan POM
7 April 2020 9 April 2015
CPOB No. 4364CPOBAIV15, Bentuk Sediaan Cairan Oral Nonbetalaktam GMP No. 4364CPOBAIV15, for Nonbetalactam Oral Liquid
Badan POM 7 April 2020
Halal
tanggal
Date
Jenis sertiikat
Certiicates
Dikeluarkan oleh
Certied by
Masa Berlaku hingga
Valid Until 5 March 2015
Halal No. 00180072030315 untuk produk Taburia kategori Suplemen dan Makanan Halal Certiicate No. 00180072030315 for Taburia products and food supplements category
LPPOM MUI 4 March 2017
Best Brand
tanggal
Date
Jenis sertiikat
Certiicates
Dikeluarkan Oleh
Certied by 4 July 2013
Biovision sebagai The 1st Champion of Indonesia Original Brand 2013 untuk kategori Eye Suplement Biovision as The 1st Champion of Indonesia Original Brand 2013 for category Eye Suplement
Majalah SWA SWA Magazine
20 September 2013 Biovision sebagai The Most Valuable Brand in Indonesia kategori Eye Suplement
BIovision as The Most Valuable Brand in Indonesia for category Eye Suplement Majalah SWA
SWA Magazine
rekor MUrI
tanggal
Date
Jenis sertiikat
Certiicates
Dikeluarkan Oleh
Certied by 08 July 2012
Piagam Penghargaan MURI No. 5500 R.MURIVII2012 atas rekor Senam Mata dan Pemeriksaan Mata dengan Peserta Terbanyak
MURI Award No. 5500R.MURI VII 2012 on Eyes Gymnastics and Examination with Most Massive Participants Museum Rekor Indonesia
Museum Record Indonesia
Acknowledgements and certifications received by the Company in the last 5 ive years are as follows:
ISO
gMP
Best Brand Halal
MURI Record
89 Annual Report 2015 PT Indofarma Persero Tbk
Managing Sustainability for Excellent Performance
LEMBaGa DaN PrOfEsI PENUNJaNG Pasar MODaL
CAPITAL MARKET SUPPORTIng InSTITUTIOnS AnD PROFESSIOnS
Informasi Perdagangan dan Pencatatan Saham
Trading Information and Stock Listing Bursa Efek Indonesia
Gedung Bursa Efek Indonesia Jl. Jend. Sudirman Kav 52-53
Jakarta 12190, Indonesia Tel.: +62 21 515 0515
Email: callcenteridx.co.id Website: www.idx.co.id
Bank Kustodian Custodian Bank
PT Kustodian Sentral Efek Indonesia Gedung Bursa Efek Indonesia, Tower 1, Lt. 5
Jl. Jend. Sudirman kav. 52-53, Jakarta 12190, Indonesia Tel.: +62 21 515 2855
Faks.: +62 21 5299 1199 Email: helpdeskksei.co.id
Website: www.ksei.co.id
Biro Administrasi Efek Securities Administration Bureau
PT Datindo Entrycom Wisma Diners Club Annex
Jl. Jend. Sudirman Kav.34-35 Jakarta 10220, Indonesia
Tel.: +62 21 570 9009 Faks.: +62 21 570 9026
Email: corporatesecretarydatindo.com Website: www.datindo.com
Agen Pemantauan Monitoring Agency
PT Bank Mandiri Persero Tbk Jl. Jenderal Gatot Subroto Kav. 36-38
Jakarta 12190, Indonesia Tel.: +62 21 524-5085, 3002-3172
Faks.: +62 21 5290 4249 Email: irbankmandiri.co.id
Website: www.bankmandiri.co.id
Akuntan Publik Public Accountant
Kantor Akuntan Publik Hendrawinata, Eddy, Siddharta Tanzil Intiland Tower 18th Floor
Jl. Jend. Sudirman Kav.32 Jakarta 10220, Indonesia
Tel.: +62 21 571 2000 Faks.: +62 21 571 1818 570 6118
Email: hes-kuningankreston-indonesia.co.id Website: www.kreston-indonesia.co.id
Notaris Notary
M. Nova Faisal, SH, M.Kn. Cyber 2 Tower, Lantai 21
